Cartesian Therapeutics
RNAC
RNAC
63 hedge funds and large institutions have $107M invested in Cartesian Therapeutics in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
52% less capital invested
Capital invested by funds: $222M → $107M (-$115M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.18M | |
| 2 | +$1.31M | |
| 3 | +$1.21M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$982K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$966K |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$7.1M | |
| 3 | -$5.19M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.73M |
| 5 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$369K |